Dexacine Trademark Details

Dexacine was registered on Tuesday, March 9, 1999 and is currently owned by Novartis Corporation under the registration number 2231046 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 14 years ago on Saturday, October 17, 2009, according to the United State Patent & Trademark Office
Word Mark Dexacine
Status Dead Registered 710 — Cancelled - Section 8
Serial Number 75070879
Registration Number 2231046
Status Date Saturday, October 17, 2009
Filing Date Saturday, October 17, 2009
Registration Date Tuesday, March 9, 1999
Attorney Maury M. Tepper, III

Correspondent

Maury M. Tepper, III
Tepper & Eyster, PLLC
3724 Benson Drive
Raleigh NC 27609

Case File Statements

Goods & Services Multiple Dose anti-Infective Steroid Combination in a Sterile Ophthalmic Ointment for Topical Application

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Saturday, October 17, 2009
First Use Anywhere Monday, October 27, 1997
First Use In Commerce Monday, October 27, 1997
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.